GLTSCR2 contributes to the death resistance and invasiveness of hypoxia-selected cancer cells

FEBS Letters

Volumn 586, Issue 19, 2012, Pages 3435-3440

  Kim, Jee Youn ^a   Park, Jae Hoon ^a   Lee, Sun ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Glioblastoma; GLTSCR2; Hypoxia; Pict 1; Tumor resistance

Indexed keywords

GLIOBLASTOMA TUMOR SUPPRESSIVE CANDIDATE REGION GENE 2 PROTEIN; NUCLEAR PROTEIN; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL DEATH; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; GLIOBLASTOMA; HYPOXIA; MALIGNANT TRANSFORMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; BASE SEQUENCE; CELL HYPOXIA; CELL LINE, TUMOR; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84866610435     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.07.064     Document Type: Article

References (26)

1. H. Chen, L. Mei, L. Zhou, X. Zhang, C. Guo, J. Li, H. Wang, Y. Zhu, Y. Zheng, and L. Huang Moesin-ezrin-radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus Int. J. Biochem. Cell Biol. 43 2011 545 555
2. J.Y. Kim, K.O. Seok, Y.J. Kim, W.K. Bae, S. Lee, and J.H. Park Involvement of GLTSCR2 in the DNA Damage Response Am. J. Pathol. 179 2011 1257 1264
3. J.H. Yim, Y.J. Kim, J.H. Ko, Y.E. Cho, S.M. Kim, J.Y. Kim, S. Lee, and J.H. Park The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death Cell Death Differ. 14 2007 1872 1979
4. Lee, S.; Kim, J.Y.; Kim, Y.J.; Seok, K.O.; Kim, J.H.; Chang, Y.J.; Kang, H.Y.; and Park, J.H. (2012) Nucleolar protein GLTSCR2 Stabilizes p53 in Response to Ribosomal Stresses. Cell Death Differ. in press.
5. Y.J. Kim, Y.E. Cho, Y.W. Kim, J.Y. Kim, S. Lee, and J.H. Park Suppression of putative tumour suppressor gene GLTSCR2 expression in human glioblastomas J. Pathol. 216 2008 218 224
6. F. Okahara, K. Itoh, A. Nakagawara, M. Murakami, Y. Kanaho, and T. Maehama Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation Mol. Biol. Cell 17 2006 4888 4895
7. M. Sasaki, K. Kawahara, M. Nishio, K. Mimori, R. Kogo, K. Hamada, B. Itoh, J. Wang, Y. Komatsu, Y.R. Yang, H. Hikasa, Y. Horie, T. Yamashita, T. Kamijo, Y. Zhang, Y. Zhu, C. Prives, T. Nakano, T.W. Mak, T. Sasaki, T. Maehama, M. Mori, and A. Suzuki Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11 Nat. Med. 17 2011 944 951
8. A.L. Harris Hypoxia: a key regulatory factor in tumour growth Nat. Rev. Cancer 2 2002 38 47
9. O. Alqawi, H.P. Wang, M. Espiritu, and G. Singh Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells Free Radic. Res. 41 2007 788 797
10. J.H. Yim, Y.J. Kim, Y.E. Cho, J.H. Ko, S.M. Kim, J.Y. Kim, and J.H. Park GLTSCR2 sensitizes cells to hypoxic injury without involvement of mitochondrial apoptotic cascades Pathobiology 74 2007 301 308
11. S. Mellberg, A. Dimberg, F. Bahram, M. Hayashi, E. Rennel, A. Ameur, J.O. Westholm, E. Larsson, P. Lindahl, M.J. Cross, and L. Claesson-Welsh Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis FASEB J. 23 2009 1490 1502
12. C.J. Sherr The INK4a/ARF network in tumour suppression Nat. Rev. Mol. Cell Biol. 2 2001 731 737
13. O. Yogev, K. Saadon, S. Anzi, K. Inoue, and E. Shaulian DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathway Cancer Res. 68 2008 1398 1406
14. C. Korgaonkar, J. Hagen, V. Tompkins, A.A. Frazier, C. Allamargot, F.W. Quelle, and D.E. Quelle Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function Mol. Cell. Biol. 25 2005 1258 1271
15. R.A. Freiberg, A.J. Krieg, A.J. Giaccia, and E.M. Hammond Checking in on hypoxia/reoxygenation Cell Cycle 5 2006 1304 1307
16. O. Soderberg, M. Gullberg, M. Jarvius, K. Ridderstrale, K.J. Leuchowius, J. Jarvius, K. Wester, P. Hydbring, F. Bahram, L.G. Larsson, and U. Landegren Direct observation of individual endogenous protein complexes in situ by proximity ligation Nat. Methods 3 2006 995 1000
17. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, and P. Kleihues The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol. 114 2007 97 109
18. Y. Kato, M. Yashiro, S. Noda, M. Tendo, S. Kashiwagi, Y. Doi, T. Nishii, J. Matsuoka, Y. Fuyuhiro, O. Shinto, T. Sawada, M. Ohira, and K. Hirakawa Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hyppo, derived from a scirrhous gastric carcinoma Br. J. Cancer 102 2010 898 907
19. A. Kieser, H.A. Weich, G. Brandner, D. Marme, and W. Kolch Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression Oncogene 9 1994 963 969
20. J.A. Royds, S.K. Dower, E.E. Qwarnstrom, and C.E. Lewis Response of tumour cells to hypoxia: role of p53 and NFkB Mol. Pathol. 51 1998 55 61
21. H.R. Mellor, and A.L. Harris The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer Cancer Metastasis Rev. 26 2007 553 566
22. E.H. Shroff, C. Snyder, and N.S. Chandel Bcl-2 family members regulate anoxia-induced cell death Antioxid. Redox. Signal. 9 2007 1405 1409
23. J.Y. Kim, Y.J. Kim, S. Lee, and J.H. Park The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells BMC Cancer. 23 2009 27 35
24. M. Paez-Ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Vinals, M. Inoue, G. Bergers, D. Hanahan, and O. Casanovas Antiantiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell. 15 2009 220 231
25. S. Loges, M. Mazzone, P. Hohensinner, and P. Carmeliet Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited Cancer Cell. 15 2009 167 170
26. O. Yogev, K. Saadon, S. Anzi, K. Inoue, and E. Shaulian DNA damage-dependent translocation of B23 and p19ARF is regulated by the Jun N-Terminal Kinase pathway Cancer Res. 68 2008 1398 1406